Enhancing Capital LLC Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Enhancing Capital LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,000 shares of the healthcare conglomerate’s stock, valued at approximately $1,012,000.

Several other large investors have also recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on UNH shares. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $499.01 on Tuesday. The stock has a market cap of $456.45 billion, a PE ratio of 32.19, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The stock has a 50-day moving average of $511.11 and a 200-day moving average of $549.15. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.